While up-regulation of CCND1 is commonly associated with increased migratory capacity, chemotherapy resistance and poor outcomes in various cancers, the down-regulation of CCND1 in breast cancer has been linked to excessively infiltrative growth and poor prognosis [84]. Here, CCND1 is linked to breast carcinoma.